首页> 外文期刊>Medicine. >Safe Contrast Volumes for Preventing Contrast-Induced Nephropathy in Elderly Patients With Relatively Normal Renal Function During Percutaneous Coronary Intervention
【24h】

Safe Contrast Volumes for Preventing Contrast-Induced Nephropathy in Elderly Patients With Relatively Normal Renal Function During Percutaneous Coronary Intervention

机译:肾功能相对正常的老年患者经皮冠状动脉介入治疗期间预防对比剂肾病的安全对比量

获取原文
           

摘要

The aim of this study was to evaluate contrast media volume to creatinine clearance (V/CrCl) ratio for predicting contrast-induced nephropathy (CIN) and to determine a safe V/CrCl cut off value to avoid CIN in elderly patients with relatively normal renal function during percutaneous coronary intervention (PCI). We prospectively enrolled 1020 consecutive elderly patients (age ≥65 years) with relative normal renal function (baseline serum creatinine 2.74 remained significantly associated with CIN (odds ratio = 3.21, 95% confidence interval [CI] 1.45–7.09, P = 0.004) and worse long-term mortality (hazard ratio = 1.96, 95% CI 1.14–3.38, P = 0.016). A V/CrCl ratio >2.74 was a significant independent predictor of CIN and was independently associated with long-term mortality in elderly patients with relatively normal renal function.
机译:这项研究的目的是评估造影剂体积与肌酐清除率(V / CrCl)的比率,以预测造影剂诱发的肾病(CIN),并确定安全的V / CrCl临界值,以避免肾脏相对正常的老年患者发生CIN经皮冠状动脉介入治疗(PCI)的功能。我们前瞻性招募了1020例肾功能相对正常的连续老年患者(年龄≥65岁)(基线血清肌酐2.74仍与CIN显着相关(比值= 3.21,95%置信区间[CI] 1.45-7.09,P = 0.004)和长期死亡率较差(危险比= 1.96,95%CI 1.14–3.38,P = 0.016)。AV / CrCl比> 2.74是CIN的重要独立预测指标,并且与年龄相对较高的老年患者的长期死亡率独立相关肾功能正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号